Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 6-heptenoic Acid, 7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl)-3,5-dihydroxy-, Monosodium Salt, (s-(r*,s*-(e)))-
2. 7-(4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyrid-3-yl)-3,5-dihydroxy-6-heptenoate Sodium Salt
3. Bay W 6228
4. Baycol
5. Cerivastatin
6. Certa
7. Kazak
8. Lipobay
9. Rivastatin
1. Baycol
2. Rivastatin
3. 143201-11-0
4. Lipobay
5. Bay W 6228
6. Certa
7. Cerivastatin Sodium [usan]
8. Cerivastatin, Sodium Salt
9. Bay-w-6228
10. Cerivastatin Na
11. Cerivastatin Sodium Salt
12. Cpd000469148
13. Chebi:3559
14. (+)-sodium (3r,5s,6e)-7-(4-(p-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridyl)-3,5-dihydroxy-6-heptenoate
15. 143201-11-0 (sodium)
16. 6q18g1060s
17. Cerivastatin (sodium)
18. Dsstox_cid_26488
19. Dsstox_rid_81659
20. Dsstox_gsid_46488
21. 6-heptanoic Acid, 7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl)-3,5-dihydroxy-(s-(r*,s*-(e)))-, Sodium Salt
22. Sodium (3r,5s,e)-7-(4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyridin-3-yl)-3,5-dihydroxyhept-6-enoate
23. Cas-143201-11-0
24. Ncgc00164625-02
25. Cerivastatinsodium
26. Unii-6q18g1060s
27. Baycol (tn)
28. 7-(4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyrid-3-yl)-3,5-dihydroxy-6-heptenoate Sodium Salt
29. Bayw6228
30. Schembl41887
31. Schembl41888
32. 6-heptenoic Acid, 7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl)-3,5-dihydroxy-, Monosodium Salt, (s-(r*,s*-(e)))-
33. Mls001424071
34. Chembl1200563
35. Dtxsid0046488
36. Cerivastatin Sodium (jan/usan)
37. Cerivastatin Sodium [jan]
38. Hms2051h13
39. Cerivastatin Sodium [vandf]
40. Cerivastatin Sodium [mart.]
41. Tox21_112244
42. Tox21_303882
43. Cerivastatin Sodium [who-dd]
44. Cerivastatin Sodium Salt [mi]
45. Akos015967306
46. Akos025149364
47. Tox21_112244_1
48. Ccg-100954
49. Nc00204
50. Cerivastatin Sodium [orange Book]
51. Ncgc00164625-04
52. Ncgc00357289-01
53. (3r,5s,6e)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoic Acid Sodium Salt
54. 6-heptenoic Acid, 7-(4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl)-3,5-dihydroxy-, Monosodium Salt, (3r,5s,6e)-
55. Smr000469148
56. Hy-109523
57. Cs-0031250
58. D00889
59. A808034
60. J-007766
61. Q27106131
62. Sodium (3r,5s,6e)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoate
63. Sodium (e,3r,5s)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoate
64. Sodium (e,3r,5s)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]-3,5-bis(oxidanyl)hept-6-enoate
65. Sodium;(e,3r,5s)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoate
| Molecular Weight | 481.5 g/mol |
|---|---|
| Molecular Formula | C26H33FNNaO5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 11 |
| Exact Mass | 481.22404560 g/mol |
| Monoisotopic Mass | 481.22404560 g/mol |
| Topological Polar Surface Area | 103 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 626 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. (See all compounds classified as Hydroxymethylglutaryl-CoA Reductase Inhibitors.)
Digital Content 
NEWS #PharmaBuzz
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
52
PharmaCompass offers a list of Cerivastatin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cerivastatin manufacturer or Cerivastatin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cerivastatin manufacturer or Cerivastatin supplier.
PharmaCompass also assists you with knowing the Cerivastatin API Price utilized in the formulation of products. Cerivastatin API Price is not always fixed or binding as the Cerivastatin Price is obtained through a variety of data sources. The Cerivastatin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A rivastatin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of rivastatin, including repackagers and relabelers. The FDA regulates rivastatin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. rivastatin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A rivastatin supplier is an individual or a company that provides rivastatin active pharmaceutical ingredient (API) or rivastatin finished formulations upon request. The rivastatin suppliers may include rivastatin API manufacturers, exporters, distributors and traders.
rivastatin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of rivastatin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right rivastatin GMP manufacturer or rivastatin GMP API supplier for your needs.
A rivastatin CoA (Certificate of Analysis) is a formal document that attests to rivastatin's compliance with rivastatin specifications and serves as a tool for batch-level quality control.
rivastatin CoA mostly includes findings from lab analyses of a specific batch. For each rivastatin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
rivastatin may be tested according to a variety of international standards, such as European Pharmacopoeia (rivastatin EP), rivastatin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (rivastatin USP).
